GSK573719/vilanterol

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK573719/vilanterol, covering 2014-03-04 to 2014-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD [Phase 3]